Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin for Septic Shock in Cirrhosis
NCT00628160Phase 3Completed
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Oct 2006
- Primary completion
- Dec 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of terlipressin in septic shock (2 arms), sponsored by Hospital Clínic de Barcelona. Primary endpoint: Hospital survival. Started Oct 2006; status: completed.
02
Drugs
terlipressin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT00628160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00628160.